Literature DB >> 21649639

Anti-tumour effects of small interfering RNA targeting anion exchanger 1 in experimental gastric cancer.

Wen-Hao Suo1, Ning Zhang, Ping-Ping Wu, Lei Zhao, Ling-Jun Song, Wei-Wei Shen, Lin Zheng, Jing Tao, Xi-Dai Long, Guo-Hui Fu.   

Abstract

BACKGROUND AND
PURPOSE: Anion exchanger 1 (AE1) is an integral membrane protein found in erythrocytes. Our previous studies have demonstrated that AE1 is expressed in human gastric cancer cells and may be involved in the carcinogenesis of cancer. In this study, we further investigated the role of AE1 in gastric carcinogenesis and the anti-tumour effects of AE1-targeted small interfering RNAs (siRNAs) in two experimental models of gastric cancer. EXPERIMENTAL APPROACH: Molecular and cellular experiments were performed to elucidate the role of AE1 in the malignant transformation of gastric epithelium and the effects of AE1-targeted siRNAs on gastric cancer cells. The anti-tumour effect of the siRNA was evaluated in vivo in two mouse models, nude mice implanted with human gastric cancer xenografts (Model I) and mice with gastric cancer induced by N-methyl-N-nitrosourea (MNU) and Helicobacter pylori (Model II). KEY
RESULTS: AE1 was found to increase gastric carcinogenesis by promoting cell proliferation. AE1-targeted siRNA significantly suppressed AE1 expression and hindered tumour growth. Furthermore, the siRNA markedly decreased the detection rate of gastric cancer, in parallel with an increase in atypical hyperplasia at the end of the experiment in Model II. CONCLUSIONS AND IMPLICATIONS: Knockdown of AE1 expression in gastric mucosa by administration of synthetic siRNAs significantly inhibits the growth of gastric cancer and decreases the detection rate of this tumour in experimental mice. These results suggest that AE1 is potentially a key therapeutic target and the silencing of AE1 expression in gastric mucosa could provide a new therapeutic approach for treating gastric cancer.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21649639      PMCID: PMC3252973          DOI: 10.1111/j.1476-5381.2011.01521.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  Anion exchangers in the red cell and beyond.

Authors:  J R Casey; R A Reithmeier
Journal:  Biochem Cell Biol       Date:  1998       Impact factor: 3.626

2.  Direct interaction and cooperative role of tumor suppressor p16 with band 3 (AE1).

Authors:  Guo-Hui Fu; Yong Wang; Yu-Hui Xi; Wei-Wei Shen; Xiao-Yan Pan; Wu-Zhong Shen; Xiao-Shu Jiang; Guo-Qiang Chen
Journal:  FEBS Lett       Date:  2005-04-11       Impact factor: 4.124

3.  Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.

Authors:  Nina Tavalai; Peer Papior; Sabine Rechter; Martina Leis; Thomas Stamminger
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Helicobacter pylori infection promotes gastric carcinogenesis in a mice model.

Authors:  Sang-Uk Han; Young-Bae Kim; Hee-Jae Joo; Ki-Baik Hahm; Won-Heung Lee; Yong-Kwan Cho; Dae-Yong Kim; Myung-Wook Kim
Journal:  J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 4.029

Review 6.  The structure and function of band 3 (AE1): recent developments (review).

Authors:  M J Tanner
Journal:  Mol Membr Biol       Date:  1997 Oct-Dec       Impact factor: 2.857

7.  E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.

Authors:  P J Guilford; J B Hopkins; W M Grady; S D Markowitz; J Willis; H Lynch; A Rajput; G L Wiesner; N M Lindor; L J Burgart; T T Toro; D Lee; J M Limacher; D W Shaw; M P Findlay; A E Reeve
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

8.  The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.

Authors:  Ki Taek Nam; Ki-Baik Hahm; Sang-Yeon Oh; Marie Yeo; Sang-Uk Han; Byeongwoo Ahn; Young-Bae Kim; Jin Seok Kang; Dong Deuk Jang; Ki-Hwa Yang; Dae-Yong Kim
Journal:  Clin Cancer Res       Date:  2004-12-01       Impact factor: 12.531

9.  Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group.

Authors:  B C Wong; S K Lam; C K Ching; W H Hu; E Kwok; J Ho; S T Yuen; Z Gao; J S Chen; K C Lai; L Y Ong; B W Chen; W H Wang; X W Jiang; X H Hou; J Y Lu
Journal:  J Gastroenterol Hepatol       Date:  1999-02       Impact factor: 4.029

10.  Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.

Authors:  Yoshiko Minakuchi; Fumitaka Takeshita; Nobuyoshi Kosaka; Hideo Sasaki; Yusuke Yamamoto; Makiko Kouno; Kimi Honma; Shunji Nagahara; Koji Hanai; Akihiko Sano; Takashi Kato; Masaaki Terada; Takahiro Ochiya
Journal:  Nucleic Acids Res       Date:  2004-07-22       Impact factor: 16.971

View more
  13 in total

1.  PCAF acts as a gastric cancer suppressor through a novel PCAF-p16-CDK4 axis.

Authors:  Hong-Jun Fei; Li-Dong Zu; Jun Wu; Xiao-Shu Jiang; Jing-Long Wang; Y Eugene Chin; Guo-Hui Fu
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

Review 2.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

3.  Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?

Authors:  Alexandre Chigaev
Journal:  Front Pharmacol       Date:  2015-07-02       Impact factor: 5.810

4.  MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.

Authors:  Wei-Wei Shen; Zhi Zeng; Wen-Xia Zhu; Guo-Hui Fu
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

5.  Regulation and roles of bicarbonate transporters in cancer.

Authors:  Andrej Gorbatenko; Christina W Olesen; Ebbe Boedtkjer; Stine F Pedersen
Journal:  Front Physiol       Date:  2014-04-16       Impact factor: 4.566

6.  Expression of AE1/p16 promoted degradation of AE2 in gastric cancer cells.

Authors:  Ting Wang; Hong-Jun Fei; Ye Yang; Xiao-Shu Jiang; Min Yan; Zhi Zeng; Jun Wu; Ling-Jun Song; Hua Tian; Guo-Hui Fu
Journal:  BMC Cancer       Date:  2016-09-05       Impact factor: 4.430

7.  Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling.

Authors:  Li-Jun Zhang; Renquan Lu; Ya-Nan Song; Jian-Yong Zhu; Wei Xia; Miao Zhang; Zhi-Yi Shao; Yan Huang; Yuqi Zhou; Hongqin Zhang; Lin Guo; Meiqin Zhang; Hong Zhang
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 8.  The role of antiangiogenic agents in the treatment of gastric cancer: A systematic review and meta-analysis.

Authors:  Xuefen Lei; Feng Wang; Yang Ke; Dong Wei; Hou Gu; Zhixian Zhang; Lifeng Jiang; Li Lv; Jie Lin; Lin Wang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 9.  Ion Channels, Transporters, and Sensors Interact with the Acidic Tumor Microenvironment to Modify Cancer Progression.

Authors:  Ebbe Boedtkjer
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 10.  Nitric oxide and pH modulation in gynaecological cancer.

Authors:  Carlos Sanhueza; Joaquín Araos; Luciano Naranjo; Eric Barros; Mario Subiabre; Fernando Toledo; Jaime Gutiérrez; Delia I Chiarello; Fabián Pardo; Andrea Leiva; Luis Sobrevia
Journal:  J Cell Mol Med       Date:  2016-07-29       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.